1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Narula, S.S. Yuan, R.W. Adams, S.E. Green, O.M. Green, J. Phillips, T.B. Zydowsky, L.D. Botfield, M.C. Hatada, M.H. Laird, E.R. Zoller, M.J. Karas, J.L. Dalgarno, D.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H12 N O6 P 261.168 n O-PHOSPHOTYROSINE PHOSPHONOTYROSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 3 1061 1073 10.1016/S0969-2126(01)00242-8 8590001 Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12734.667 SYK PROTEIN TYROSINE KINASE 2.7.1.112 C-TERMINAL SH2 DOMAIN 1 man polymer THE LIGAND IS A PHOSPHOTYROSINE CONTAINING PEPTIDE DERIVED FROM THE HIGH-AFFINITY IGE RECEPTOR 729.693 ACETYL-THR-PTR-GLU-THR-LEU-NH2 1 man polymer no no GSRRASVGSHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKK FDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQ GSRRASVGSHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKK FDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQ A polypeptide(L) no yes (ACE)T(PTR)ETL(NH2) XTYETLX B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample BL21 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 (DE3) BL21 human Homo Escherichia Escherichia coli sample RECOMBINANT CONSTRUCT ADDED TO PROTEIN DOMAIN 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 (DE3) repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 1996-11-08 1 1 2008-03-24 1 2 2011-07-13 1 3 2012-02-22 Y 1995-10-03 REL 1 1 BRUNGER refinement X-PLOR GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A ARG 3 n 3 ARG 3 A ARG 4 n 4 ARG 4 A ALA 5 n 5 ALA 5 A SER 6 n 6 SER 6 A VAL 7 n 7 VAL 7 A GLY 8 n 8 GLY 8 A SER 9 n 9 SER 9 A HIS 10 n 10 HIS 10 A GLU 11 n 11 GLU 11 A LYS 12 n 12 LYS 12 A MET 13 n 13 MET 13 A PRO 14 n 14 PRO 14 A TRP 15 n 15 TRP 15 A PHE 16 n 16 PHE 16 A HIS 17 n 17 HIS 17 A GLY 18 n 18 GLY 18 A LYS 19 n 19 LYS 19 A ILE 20 n 20 ILE 20 A SER 21 n 21 SER 21 A ARG 22 n 22 ARG 22 A GLU 23 n 23 GLU 23 A GLU 24 n 24 GLU 24 A SER 25 n 25 SER 25 A GLU 26 n 26 GLU 26 A GLN 27 n 27 GLN 27 A ILE 28 n 28 ILE 28 A VAL 29 n 29 VAL 29 A LEU 30 n 30 LEU 30 A ILE 31 n 31 ILE 31 A GLY 32 n 32 GLY 32 A SER 33 n 33 SER 33 A LYS 34 n 34 LYS 34 A THR 35 n 35 THR 35 A ASN 36 n 36 ASN 36 A GLY 37 n 37 GLY 37 A LYS 38 n 38 LYS 38 A PHE 39 n 39 PHE 39 A LEU 40 n 40 LEU 40 A ILE 41 n 41 ILE 41 A ARG 42 n 42 ARG 42 A ALA 43 n 43 ALA 43 A ARG 44 n 44 ARG 44 A ASP 45 n 45 ASP 45 A ASN 46 n 46 ASN 46 A ASN 47 n 47 ASN 47 A GLY 48 n 48 GLY 48 A SER 49 n 49 SER 49 A TYR 50 n 50 TYR 50 A ALA 51 n 51 ALA 51 A LEU 52 n 52 LEU 52 A CYS 53 n 53 CYS 53 A LEU 54 n 54 LEU 54 A LEU 55 n 55 LEU 55 A HIS 56 n 56 HIS 56 A GLU 57 n 57 GLU 57 A GLY 58 n 58 GLY 58 A LYS 59 n 59 LYS 59 A VAL 60 n 60 VAL 60 A LEU 61 n 61 LEU 61 A HIS 62 n 62 HIS 62 A TYR 63 n 63 TYR 63 A ARG 64 n 64 ARG 64 A ILE 65 n 65 ILE 65 A ASP 66 n 66 ASP 66 A LYS 67 n 67 LYS 67 A ASP 68 n 68 ASP 68 A LYS 69 n 69 LYS 69 A THR 70 n 70 THR 70 A GLY 71 n 71 GLY 71 A LYS 72 n 72 LYS 72 A LEU 73 n 73 LEU 73 A SER 74 n 74 SER 74 A ILE 75 n 75 ILE 75 A PRO 76 n 76 PRO 76 A GLU 77 n 77 GLU 77 A GLY 78 n 78 GLY 78 A LYS 79 n 79 LYS 79 A LYS 80 n 80 LYS 80 A PHE 81 n 81 PHE 81 A ASP 82 n 82 ASP 82 A THR 83 n 83 THR 83 A LEU 84 n 84 LEU 84 A TRP 85 n 85 TRP 85 A GLN 86 n 86 GLN 86 A LEU 87 n 87 LEU 87 A VAL 88 n 88 VAL 88 A GLU 89 n 89 GLU 89 A HIS 90 n 90 HIS 90 A TYR 91 n 91 TYR 91 A SER 92 n 92 SER 92 A TYR 93 n 93 TYR 93 A LYS 94 n 94 LYS 94 A ALA 95 n 95 ALA 95 A ASP 96 n 96 ASP 96 A GLY 97 n 97 GLY 97 A LEU 98 n 98 LEU 98 A LEU 99 n 99 LEU 99 A ARG 100 n 100 ARG 100 A VAL 101 n 101 VAL 101 A LEU 102 n 102 LEU 102 A THR 103 n 103 THR 103 A VAL 104 n 104 VAL 104 A PRO 105 n 105 PRO 105 A CYS 106 n 106 CYS 106 A GLN 107 n 107 GLN 107 A LYS 108 n 108 LYS 108 A ILE 109 n 109 ILE 109 A GLY 110 n 110 GLY 110 A THR 111 n 111 THR 111 A GLN 112 n 112 GLN 112 A ACE 0 n 1 ACE 0 B THR 1 n 2 THR 1 B PTR 2 n 3 PTR 2 B GLU 3 n 4 GLU 3 B THR 4 n 5 THR 4 B LEU 5 n 6 LEU 5 B NH2 6 n 7 NH2 6 B author_defined_assembly 2 dimeric B PTR 2 O-PHOSPHOTYROSINE B PTR 3 TYR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LEU 40 A O LEU 40 A N CYS 53 A N CYS 53 A O TYR 50 A O TYR 50 A N ILE 65 A N ILE 65 1 A SER 2 49.24 88.66 1 A ARG 3 -169.04 35.02 1 A ARG 4 52.79 166.85 1 A ALA 5 -85.95 -90.53 1 A SER 9 46.03 73.49 1 A HIS 10 -69.91 81.58 1 A LYS 12 -36.31 106.45 1 A MET 13 153.13 158.31 1 A TRP 15 -67.69 9.08 1 A LYS 19 -124.16 -53.37 1 A ILE 20 -41.93 164.52 1 A SER 21 -90.23 -73.66 1 A ARG 22 -178.47 -40.28 1 A SER 33 139.50 -127.46 1 A LYS 34 82.12 -57.53 1 A THR 35 -60.15 3.22 1 A ASN 36 52.76 99.25 1 A ARG 44 -83.82 -155.34 1 A ASP 45 -161.01 84.99 1 A ASN 46 -172.27 -53.94 1 A ASN 47 177.94 132.22 1 A ALA 51 -170.32 130.46 1 A HIS 56 -79.48 -98.71 1 A LYS 67 -90.61 -152.55 1 A ASP 68 -144.67 50.65 1 A LYS 69 47.34 29.44 1 A SER 74 -170.31 -169.54 1 A LYS 79 -137.01 -140.15 1 A ASP 96 72.48 -10.29 1 A LEU 98 -49.06 179.86 1 A VAL 101 -52.23 177.05 1 A THR 103 -151.02 -37.27 1 A CYS 106 -91.03 -64.10 1 A GLN 107 -33.26 161.88 1 A LYS 108 -57.19 -177.74 1 A ILE 109 -95.73 -122.08 1 A THR 111 -88.55 -83.52 model building X-PLOR refinement X-PLOR phasing X-PLOR SYK PROTEIN TYROSINE KINASE, ACETYL-THR-PTR-GLU-THR-LEU-NH2 SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR, NMR 1 N N 2 N N A GLU 23 A GLU 23 HELX_P A ILE 31 A ILE 31 1 1 9 A LEU 84 A LEU 84 HELX_P A TYR 93 A TYR 93 1 2 10 covale 1.341 B ACE 0 B C ACE 1 1_555 B THR 1 B N THR 2 1_555 covale 1.336 B PTR 2 B N PTR 3 1_555 B THR 1 B C THR 2 1_555 covale 1.334 B PTR 2 B C PTR 3 1_555 B GLU 3 B N GLU 4 1_555 covale 1.345 B NH2 6 B N NH2 7 1_555 B LEU 5 B C LEU 6 1_555 COMPLEX (PHOSPHOTRANSFERASE/PEPTIDE) PROTEIN-TYROSINE KINASE SH2 DOMAIN, COMPLEX (PHOSPHOTRANSFERASE-PEPTIDE), COMPLEX (PHOSPHOTRANSFERASE-PEPTIDE) complex KSYK_HUMAN UNP 1 1 P43405 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGR THASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIAT TAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQL VEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSF NPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVA VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV LMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1CSZ PDB 2 1CSZ 163 265 1CSZ 10 112 P43405 A 1 10 112 0 6 1CSZ 0 6 1CSZ B 2 1 7 3 anti-parallel anti-parallel A PHE 39 A PHE 39 A ALA 43 A ALA 43 A TYR 50 A TYR 50 A LEU 55 A LEU 55 A LYS 59 A LYS 59 A ILE 65 A ILE 65 BINDING SITE FOR RESIDUE NH2 B 6 Software 3 A GLY 97 A GLY 97 3 1_555 B THR 4 B THR 5 3 1_555 B LEU 5 B LEU 6 3 1_555 1 P 1